KRESLADI
STN: 125806
Proper Name: marnetegragene autotemcel
Tradename: KRESLADI
Manufacturer: Rocket Pharmaceuticals, Inc.
Indication:
- For the treatment of pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I) due to biallelic variants in ITGB2 without an available human leukocyte antigen (HLA)-matched sibling donor for allogeneic hematopoietic stem cell transplant.